| |
| |
|
| Insider
Information: |
Lunger John |
| Relationship: |
Chief Patient Supply O... |
| City: |
Villonova |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
19,015 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,441 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,015 |
|
|
| Total
Value |
$20,441 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adaptimmune Therapeutics PLC |
ADAP |
Chief Patient Supply O... |
2024-01-17 |
19,015 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2024-01-17 |
4 |
S |
$0.67 |
$12,191 |
D/D |
(18,114) |
19,015 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2024-01-16 |
4 |
S |
$0.79 |
$3,698 |
D/D |
(4,681) |
7,023 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2024-01-12 |
4 |
S |
$0.85 |
$4,458 |
D/D |
(5,220) |
7,874 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2024-01-11 |
4 |
S |
$0.84 |
$3,354 |
D/D |
(4,009) |
6,104 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2023-08-01 |
4 |
S |
$0.91 |
$2,804 |
D/D |
(3,096) |
4,718 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2023-01-17 |
4 |
S |
$1.86 |
$8,250 |
D/D |
(4,440) |
7,264 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2023-01-12 |
4 |
S |
$1.71 |
$8,484 |
D/D |
(4,973) |
8,121 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2023-01-11 |
4 |
S |
$1.75 |
$6,713 |
D/D |
(3,843) |
6,270 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2023-01-04 |
4 |
S |
$1.69 |
$1,863 |
D/D |
(1,100) |
1,725 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2022-08-01 |
4 |
S |
$1.77 |
$5,290 |
D/D |
(2,983) |
4,829 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2022-07-05 |
4 |
S |
$1.68 |
$3,311 |
D/D |
(1,973) |
3,104 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2022-01-18 |
4 |
S |
$3.19 |
$13,942 |
D/D |
(4,368) |
7,336 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2022-01-12 |
4 |
S |
$3.54 |
$3,813 |
D/D |
(1,076) |
1,749 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2022-01-11 |
4 |
S |
$3.56 |
$13,409 |
D/D |
(3,770) |
6,343 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2022-01-04 |
4 |
S |
$4.06 |
$4,349 |
D/D |
(1,070) |
1,755 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2021-08-02 |
4 |
S |
$3.58 |
$10,536 |
D/D |
(2,939) |
4,873 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2021-07-02 |
4 |
S |
$4.26 |
$8,133 |
D/D |
(1,907) |
3,170 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2021-01-19 |
4 |
S |
$5.67 |
$24,708 |
D/D |
(4,358) |
7,346 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2021-01-12 |
4 |
S |
$6.15 |
$6,509 |
D/D |
(1,058) |
1,767 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2021-01-04 |
4 |
S |
$5.33 |
$5,674 |
D/D |
(1,065) |
1,760 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2020-08-03 |
4 |
S |
$9.25 |
$44,613 |
D/D |
(4,823) |
8,066 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2020-01-14 |
4 |
S |
$5.13 |
$5,874 |
D/D |
(1,144) |
1,681 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply Officer |
• – – |
2020-01-06 |
4 |
S |
$1.20 |
$1,378 |
D/D |
(1,148) |
1,677 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Patient Supply OfficerOf |
• – – |
2019-08-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,806 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
